NASDAQ:PRE Prenetics Global Q3 2026 Earnings Date & Estimates $20.60 -0.67 (-3.15%) Closing price 10/14/2026 04:00 PM EasternExtended Trading$20.58 -0.02 (-0.10%) As of 10/14/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Prenetics Global is estimated to report Q3 2026 earnings on Monday, November 9, 2026, before market opens. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 9, 2026TimeBefore Market OpensConference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Prenetics Global in Q3 2026Prenetics Global is expected to post earnings of -$0.8543 per share on revenue of $63.25 million. In the same quarter a year earlier Prenetics Global reported -$0.41 per share on revenue of $23.56 million. Prenetics Global last reported on August 19, 2026, posting -$0.53 per share and beating the -$0.84 consensus estimate. Prenetics Global has beaten the consensus EPS estimate in 4 of its last 5 quarters.Consensus EstimatesConsensus EPS-$0.8543Expected Revenue$63.25 millionPrior-Year EPS-$0.41Prior-Year Revenue$23.56 millionExpected Revenue Growth+168.5%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.53 (Beat by +$0.31)Last Quarter Revenue$46.49 millionEPS Beat Rate4 of last 5 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Prenetics Global Q3 2026 Earnings FAQ When does Prenetics Global report Q3 2026 earnings? Prenetics Global (NASDAQ:PRE) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Prenetics Global's Q3 2026 earnings call? Prenetics Global's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Prenetics Global? Analysts expect Prenetics Global to post earnings of -$0.8543 per share for Q3 2026. How much revenue is Prenetics Global expected to report? The consensus revenue estimate for Prenetics Global is $63.25 million for Q3 2026. Prenetics Global Earnings HeadlinesPrenetics’ IM8 Strikes Multiyear Deal as NBA’s Official Nutrition Partner in Australia and Southeast AsiaOctober 13 at 7:30 AM | tipranks.comLucid Capital Markets initiates coverage of Prenetics Global with buyOctober 12 at 5:39 PM | msn.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. | Stansberry Research (Ad)NBA Names IM8 Official Nutrition Partner in Australia and Southeast AsiaOctober 12 at 9:51 AM | quiverquant.comQIs Prenetics Global Ltd (PRE) a Bargain After 8.1% Drop? GF Value Says UndervaluedOctober 3, 2026 | gurufocus.comCraig-Hallum initiates coverage of Prenetics Global with buySeptember 18, 2026 | msn.comSee More Prenetics Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email. Email Address About Prenetics GlobalPrenetics Global (NASDAQ:PRE) is a health sciences and genomics company focused on making precision healthcare more accessible. The company develops and provides genetic testing, clinical genomics, diagnostics and related digital health services for consumers, healthcare professionals and enterprises. Its offerings include CircleDNA, a consumer genetic-testing platform that provides information related to ancestry, wellness and selected health traits, and ACT Genomics, which provides genomic profiling and precision oncology services intended to help physicians and cancer patients make more informed treatment decisions. Prenetics has also pursued early cancer-detection technologies through Insighta, a joint venture focused on blood-based screening research and development. Founded in Hong Kong in 2014, Prenetics serves customers and healthcare organizations across markets including Asia, the United States and the United Kingdom. The company was listed on the Nasdaq in 2022 following a business combination with Artisan Acquisition Corp. Prenetics was founded by Danny Yeung, who serves as its chief executive officer.View Prenetics Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
